104 related articles for article (PubMed ID: 20587805)
1. Evolution of the TSC1/TSC2-TOR signaling pathway.
Serfontein J; Nisbet RE; Howe CJ; de Vries PJ
Sci Signal; 2010 Jun; 3(128):ra49. PubMed ID: 20587805
[TBL] [Abstract][Full Text] [Related]
2. Tuberous sclerosis complex regulates Drosophila neuromuscular junction growth via the TORC2/Akt pathway.
Natarajan R; Trivedi-Vyas D; Wairkar YP
Hum Mol Genet; 2013 May; 22(10):2010-23. PubMed ID: 23393158
[TBL] [Abstract][Full Text] [Related]
3. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling.
Gao X; Zhang Y; Arrazola P; Hino O; Kobayashi T; Yeung RS; Ru B; Pan D
Nat Cell Biol; 2002 Sep; 4(9):699-704. PubMed ID: 12172555
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway.
Kapahi P; Zid BM; Harper T; Koslover D; Sapin V; Benzer S
Curr Biol; 2004 May; 14(10):885-90. PubMed ID: 15186745
[TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
[TBL] [Abstract][Full Text] [Related]
6. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
Kwiatkowski DJ; Manning BD
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R251-8. PubMed ID: 16244323
[TBL] [Abstract][Full Text] [Related]
7. Diet and energy-sensing inputs affect TorC1-mediated axon misrouting but not TorC2-directed synapse growth in a Drosophila model of tuberous sclerosis.
Dimitroff B; Howe K; Watson A; Campion B; Lee HG; Zhao N; O'Connor MB; Neufeld TP; Selleck SB
PLoS One; 2012; 7(2):e30722. PubMed ID: 22319582
[TBL] [Abstract][Full Text] [Related]
8. A reliable cell-based assay for testing unclassified TSC2 gene variants.
Coevoets R; Arican S; Hoogeveen-Westerveld M; Simons E; van den Ouweland A; Halley D; Nellist M
Eur J Hum Genet; 2009 Mar; 17(3):301-10. PubMed ID: 18854862
[TBL] [Abstract][Full Text] [Related]
9. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
[TBL] [Abstract][Full Text] [Related]
10. TSC1/2 tumour suppressor complex maintains Drosophila germline stem cells by preventing differentiation.
Sun P; Quan Z; Zhang B; Wu T; Xi R
Development; 2010 Aug; 137(15):2461-9. PubMed ID: 20573703
[TBL] [Abstract][Full Text] [Related]
11. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of tor1 and tor2 on nitrogen starvation responses in fission yeast.
Weisman R; Roitburg I; Schonbrun M; Harari R; Kupiec M
Genetics; 2007 Mar; 175(3):1153-62. PubMed ID: 17179073
[TBL] [Abstract][Full Text] [Related]
13. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
Nobukini T; Thomas G
Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
[TBL] [Abstract][Full Text] [Related]
14. Role of TSC-mTOR pathway in diabetic nephropathy.
Inoki K
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S59-62. PubMed ID: 18926585
[TBL] [Abstract][Full Text] [Related]
15. The expanding TOR signaling network.
Martin DE; Hall MN
Curr Opin Cell Biol; 2005 Apr; 17(2):158-66. PubMed ID: 15780592
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of TSC-mediated control of synapse assembly and axon guidance.
Knox S; Ge H; Dimitroff BD; Ren Y; Howe KA; Arsham AM; Easterday MC; Neufeld TP; O'Connor MB; Selleck SB
PLoS One; 2007 Apr; 2(4):e375. PubMed ID: 17440611
[TBL] [Abstract][Full Text] [Related]
17. Growth control under stress: mTOR regulation through the REDD1-TSC pathway.
Ellisen LW
Cell Cycle; 2005 Nov; 4(11):1500-02. PubMed ID: 16258273
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
Ma L; Chen Z; Erdjument-Bromage H; Tempst P; Pandolfi PP
Cell; 2005 Apr; 121(2):179-93. PubMed ID: 15851026
[TBL] [Abstract][Full Text] [Related]
19. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.
El-Hashemite N; Zhang H; Henske EP; Kwiatkowski DJ
Lancet; 2003 Apr; 361(9366):1348-9. PubMed ID: 12711473
[TBL] [Abstract][Full Text] [Related]
20. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
Avruch J; Hara K; Lin Y; Liu M; Long X; Ortiz-Vega S; Yonezawa K
Oncogene; 2006 Oct; 25(48):6361-72. PubMed ID: 17041622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
